Clinical Trial

Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
The purpose of this study is to examine whether treatment of pregnant Malawian women with repeated doses of sulfadoxine-pyrimethamine and azithromycin antibiotics will prevent preterm deliveries and result in other health benefits both for the mother and the foetus/newborn.
Protocol Amendment History 12 amendments
This ClinicalTrials.gov record has been amended 12 times since 2005-08-16; most recent amendment 2025-03-24.
Status change: Completed → Active, Not Recruiting 2019-12-27
Status change: Active, Not Recruiting → Completed 2012-06-17
Status change: Recruiting → Active, Not Recruiting 2007-04-18
Trial Details
NCT Number NCT00131235
Lead Sponsor Tampere University
Collaborators: Academy of Finland, Foundation for Paediatric Research, Finland
Conditions Malaria, Sexually Transmitted Diseases, Preterm Birth, Pregnancy
Enrollment 1,320 participants
Start Date 2003-12
Primary Completion 2007-06 (estimated)
Study Completion 2027-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-25